About the Authors

Vivek Subbiah

vsubbiah@mdanderson.org

Affiliations Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas

Aung Naing

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas

Robert E. Brown

Affiliation Department of Pathology and Laboratory Medicine, UT Health, University of Texas–Houston Medical School, Houston, Texas

Helen Chen

Affiliation Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland

Laurence Doyle

Affiliation Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland

Patricia LoRusso

Affiliation Wayne State University–Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Robert Benjamin

Affiliation Division of Cancer Medicine, Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas

Pete Anderson

Affiliation Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas

Razelle Kurzrock

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: VS AN REB RK. Performed the experiments: VS AN REB RK. Analyzed the data: VS AN REB HC PA RK. Contributed reagents/materials/analysis tools: VS AN REB HC LD PL RB PA RK. Wrote the paper: VS REB RK.